{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T09:29:26Z","timestamp":1766395766718,"version":"3.48.0"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bcp.2025.117575","type":"journal-article","created":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T06:26:36Z","timestamp":1764483996000},"page":"117575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Systematic review and synthesis without meta-analysis (SWiM) reveals lack of clinical studies and weak preclinical evidence for interaction between glucose regulating drugs and environmental contaminant exposure"],"prefix":"10.1016","volume":"244","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2168-6112","authenticated-orcid":false,"given":"K.A.","family":"Bennett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gouleguine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.L.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117575_b0075","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/fee.1450","article-title":"Synthetic chemicals as agents of global change","volume":"15","author":"Bernhardt","year":"2017","journal-title":"Front. Ecol. Environ."},{"key":"10.1016\/j.bcp.2025.117575_b0595","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1021\/acs.est.1c04158","article-title":"Outside the safe operating space of the planetary boundary for novel entities","volume":"56","author":"Persson","year":"2022","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.bcp.2025.117575_b0410","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(17)32345-0","article-title":"The Lancet Commission on pollution and health","volume":"391","author":"Landrigan","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2025.117575_b0190","unstructured":"Eurostat (2024) Chemicals consumption and production statistics. https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Chemicals_production_and_consumption_statistics (Accessed 12th November 2025)."},{"key":"10.1016\/j.bcp.2025.117575_b0175","unstructured":"EEA (2024) Growth of the EU chemicals market for substances of different levels of concern (Indicator)\u2019 (https:\/\/www.eea.europa.eu\/en\/european-zero-pollution-dashboards\/indicators\/growth-of-the-eu-chemicals-market-for-substances-of-different-levels-of-concern) accessed 12th November 2025."},{"key":"10.1016\/j.bcp.2025.117575_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40572-020-00261-w","article-title":"Synthetic chemical trade as a potential driver of global health disparities and data gaps on synthetic chemicals in vulnerable populations","volume":"7","author":"Goodman","year":"2020","journal-title":"Curr. Environ. Health Rep."},{"key":"10.1016\/j.bcp.2025.117575_b0230","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1016\/S2542-5196(22)00090-0","article-title":"Pollution and health: a progress update","volume":"6","author":"Fuller","year":"2022","journal-title":"Lancet Planet Health."},{"key":"10.1016\/j.bcp.2025.117575_b0330","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41370-022-00428-7","article-title":"Linking complex disease and exposure data-insights from an environmental and occupational health study","volume":"33","author":"Ives","year":"2023","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"10.1016\/j.bcp.2025.117575_b0835","first-page":"15","article-title":"Biomonitoring xenobiotics in human biospecimens: challenges, advances, and the future of exposome characterization","volume":"263","author":"Zhu","year":"2025","journal-title":"Rev. Env. Contam. (formerly: Residue Reviews)"},{"key":"10.1016\/j.bcp.2025.117575_b0270","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s43856-024-00513-y","article-title":"Machine learning-based health environmental-clinical risk scores in European children","volume":"4","author":"Guimbaud","year":"2024","journal-title":"Commun Med (lond)."},{"key":"10.1016\/j.bcp.2025.117575_b0725","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s12931-024-03000-z","article-title":"Development and evaluation of a questionnaire to capture environmental and occupational inhalational exposures in adults with fibrotic interstitial lung disease","volume":"25","author":"Swaminathan","year":"2024","journal-title":"Respir. Res."},{"key":"10.1016\/j.bcp.2025.117575_b0125","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","article-title":"The global burden of metabolic disease: Data from 2000 to 2019","volume":"35","author":"Chew","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2025.117575_b0255","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2021.05.022","article-title":"Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019","volume":"75","author":"Golabi","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2025.117575_b0320","unstructured":"International Diabetes Federation. (2025) IDF Diabetes Atlas, 11th edn. Brussels, Belgium: Available at: https:\/\/diabetesatlas.org."},{"key":"10.1016\/j.bcp.2025.117575_b0830","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.891929","article-title":"The Global Burden of Diseases attributed to high low-density lipoprotein cholesterol from 1990 to 2019","volume":"10","author":"Zheng","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.bcp.2025.117575_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.118574","article-title":"Endocrine disrupting chemicals exposure and health: an umbrella review","volume":"302","author":"Chen","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.bcp.2025.117575_b0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.envint.2018.01.023","article-title":"Excretion of Di-2-ethylhexyl phthalate (DEHP) metabolites in urine is related to body mass index because of higher energy intake in the overweight and obese","volume":"113","author":"Campbell","year":"2018","journal-title":"Environ. Int."},{"key":"10.1016\/j.bcp.2025.117575_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2019.109017","article-title":"Quantitative bias analysis of the association between subclinical thyroid disease and two perfluoroalkyl substances in a single study","volume":"182","author":"Dzierlenga","year":"2020","journal-title":"Environ. Res."},{"key":"10.1016\/j.bcp.2025.117575_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152845","article-title":"Why is elevation of serum cholesterol associated with exposure to perfluoroalkyl substances (PFAS) in humans? a workshop report on potential mechanisms","volume":"459","author":"Andersen","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2025.117575_b0510","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3390\/antiox14040421","article-title":"Environmental health is overlooked in longevity research","volume":"14","author":"Mesnage","year":"2025","journal-title":"Antioxidants."},{"key":"10.1016\/j.bcp.2025.117575_b0605","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1055\/a-2198-9307","article-title":"Endocrine disruptors: focus on the adrenal Cortex","volume":"56","author":"P\u00f6tzl","year":"2024","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.bcp.2025.117575_b0785","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41576-022-00569-3","article-title":"Molecular mechanisms of environmental exposures and human disease","volume":"24","author":"Wu","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bcp.2025.117575_b0810","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-019-09521-z","article-title":"Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention","volume":"21","author":"Yilmaz","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.bcp.2025.117575_b0145","doi-asserted-by":"crossref","unstructured":"M.J. Davies, V.R. Aroda, B.S. Collins, R.A. Gabbay, J. Green, Maruthur NM, Rosas SE, Del Prato S, Mathieu C, Mingrone G, Rossing P, Tankova T, Tsapas A, Buse JB. Management of Hyperglycemia in Type 2 Diabetes, (2022). A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 45(11):2753-2786. doi: 10.2337\/dci22-0034.","DOI":"10.2337\/dci22-0034"},{"key":"10.1016\/j.bcp.2025.117575_b0295","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/diacare.23.11.1660","article-title":"Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes","volume":"23","author":"Horton","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2025.117575_b0325","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3390\/ph16121714","article-title":"Metformin: the winding path from understanding its molecular mechanisms to proving therapeutic benefits in neurodegenerative disorders","volume":"16","author":"Isop","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bcp.2025.117575_b0620","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2025.117575_b0710","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","article-title":"PPAR\u03b3: adipogenic regulator and thiazolidinedione receptor","volume":"47","author":"Spiegelman","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2025.117575_bib836","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2337\/diacare.15.6.737","article-title":"Sulfonylureas in NIDDM","volume":"15","author":"Groop","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2025.117575_b0305","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0022-3565(24)39254-7","article-title":"Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: a comparison with sulfonylureas and repaglinide","volume":"293","author":"Hu","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"358","key":"10.1016\/j.bcp.2025.117575_b0165","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0140-6736(01)06715-0","article-title":"Insulinotropic meglitinide analogues","volume":"17","author":"Dornhorst","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2025.117575_b0735","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1021\/jm030091l","article-title":"1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties","volume":"46","author":"Villhauer","year":"2003","journal-title":"J. Med. Chem."},{"issue":"S1","key":"10.1016\/j.bcp.2025.117575_b0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1463-1326.2007.00765.x","article-title":"Incretin-based treatment of type 2 diabetes: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors","volume":"9","author":"Deacon","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bcp.2025.117575_b0020","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1210\/jc.2003-031907","article-title":"Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes","volume":"89","author":"Ahr\u00e9n","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2025.117575_b0060","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1210\/jc.2006-1882","article-title":"The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients","volume":"92","author":"Balas","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2025.117575_b0480","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1210\/jc.2004-2460","article-title":"Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes","volume":"90","author":"Mari","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"S1","key":"10.1016\/j.bcp.2025.117575_b0575","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1463-1326.2007.00763.x","article-title":"The DPP-4 inhibitor vildagliptin: robust glycaemic control in type 2 diabetes and beyond","volume":"9","author":"Panina","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bcp.2025.117575_b0405","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/clpt.2008.250","article-title":"Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus","volume":"85","author":"Komoroski","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2025.117575_b0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11892-021-01442-z","article-title":"Renal protection with SGLT2 inhibitors: effects in acute and chronic kidney disease","volume":"22","author":"Bailey","year":"2022","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.bcp.2025.117575_b0290","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15326","article-title":"Estimation of the direct health and indirect societal costs of diabetes in the UK using a cost of illness model","volume":"41","author":"Hex","year":"2024","journal-title":"Diabet. Med."},{"key":"10.1016\/j.bcp.2025.117575_b0350","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117575_b0615","doi-asserted-by":"crossref","first-page":"71","DOI":"10.12669\/pjms.35.1.100","article-title":"(2019) Variability in the therapeutic response of metformin treatment in patients with type 2 diabetes mellitus","volume":"35","author":"Rashid","year":"2019","journal-title":"Pak J Med Sci."},{"key":"10.1016\/j.bcp.2025.117575_b0455","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2337\/dc08-1863","article-title":"Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes","volume":"32","author":"List","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2025.117575_b0640","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2337\/diacare.27.6.1265","article-title":"Repaglinide versus nateglinide monotherapy: a randomized, multicenter study","volume":"27","author":"Rosenstock","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2025.117575_b0210","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.2337\/dc10-0612","article-title":"Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial","volume":"33","author":"Ferrannini","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2025.117575_b0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/dc17-0417","article-title":"(2018) Efficacy and safety of once-Weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial","volume":"41","author":"Ahmann","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2025.117575_b0085","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/jdi.13636","article-title":"Retrospective nationwide study on the trends in first-line antidiabetic medication for patients with type\u20092 diabetes in Japan","volume":"13","author":"Bouchi","year":"2022","journal-title":"J Diabetes Investig."},{"key":"10.1016\/j.bcp.2025.117575_b0225","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117575_b0105","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1463-1326.2010.01248.x","article-title":"A review of treatment response in type 2 diabetes: assessing the role of patient heterogeneity","volume":"12","author":"Cantrell","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bcp.2025.117575_b0490","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/dme.12688","article-title":"Predictors of response in initial users of metformin and sulphonylurea derivatives: a systematic review","volume":"32","author":"Martono","year":"2015","journal-title":"Diabet. Med."},{"key":"10.1016\/j.bcp.2025.117575_b0150","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2337\/dc21-1152","article-title":"'t Hart LM, Giacomini KM, Pearson ER; for MetGen Plus, for the DIRECT Consortium; MetGen Plus investigators (2021) Genome-wide meta-analysis identifies genetic variants associated with glycemic response to sulfonylureas","volume":"44","author":"Dawed","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2025.117575_b0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S2213-8587(22)00340-0","article-title":"Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials","volume":"11","author":"Dawed","year":"2023","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bcp.2025.117575_b0395","doi-asserted-by":"crossref","first-page":"9800","DOI":"10.3390\/ijms22189800","article-title":"Treatment response to SGLT2 inhibitors: from clinical characteristics to genetic variations","volume":"22","author":"Klen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117575_b0585","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1183879","article-title":"Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis","volume":"11","author":"Peng","year":"2023","journal-title":"Front. Public Health"},{"key":"10.1016\/j.bcp.2025.117575_b0655","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/jpm13030489","article-title":"Identification of transporter polymorphisms influencing metformin pharmacokinetics in healthy volunteers","volume":"13","author":"Saiz-Rodr\u00edguez","year":"2023","journal-title":"J Pers Med."},{"key":"10.1016\/j.bcp.2025.117575_b0780","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2337\/dc22-2494","article-title":"Genome-wide association study identifies pharmacogenomic variants associated with metformin glycemic response in African American patients with type 2 diabetes","volume":"47","author":"Wu","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bcp.2025.117575_b0440","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-086594","article-title":"iDiabetes platform-enhanced phenotyping of patients with diabetes for precision diagnosis, prognosis and treatment: study protocol for a cluster-randomised controlled study in Tayside, Scotland","volume":"14","author":"Lin","year":"2024","journal-title":"BMJ Open."},{"key":"10.1016\/j.bcp.2025.117575_b0400","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cmet.2020.07.012","article-title":"Microbial imidazole propionate affects responses to metformin through p38\u03b3-dependent inhibitory AMPK phosphorylation","volume":"32","author":"Koh","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2025.117575_b0235","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz1803","article-title":"Epigenetic markers associated with metformin response and intolerance in drug-na\u00efve patients with type 2 diabetes","volume":"12","author":"Garc\u00eda-Calz\u00f3n","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2025.117575_b0690","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12933-020-0990-2","article-title":"Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients","volume":"19","author":"Shao","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bcp.2025.117575_b0570","article-title":"(2021) the PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.bcp.2025.117575_b0100","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.bcp.2025.117575_b0530","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.envint.2018.07.015","article-title":"Identifying the PECO: a framework for formulating good questions to explore the association of environmental and other exposures with health outcomes","volume":"121","author":"Morgan","year":"2018","journal-title":"Environ. Int."},{"key":"10.1016\/j.bcp.2025.117575_b0110","doi-asserted-by":"crossref","first-page":"56001","DOI":"10.1289\/EHP10343","article-title":"Systematic evidence map for over one hundred and fifty per- and polyfluoroalkyl substances (PFAS)","volume":"130","author":"Carlson","year":"2022","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bcp.2025.117575_b0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.NAJ.0000446779.99522.f6","article-title":"Constructing a search strategy and searching for evidence. a guide to the literature search for a systematic review","volume":"114","author":"Aromataris","year":"2014","journal-title":"Am. J. Nurs."},{"key":"10.1016\/j.bcp.2025.117575_b0495","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem. Med."},{"key":"10.1016\/j.bcp.2025.117575_b0675","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.toxlet.2009.05.013","article-title":"ToxRTool, a new tool to assess the reliability of toxicological data","volume":"189","author":"Schneider","year":"2009","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bcp.2025.117575_b0645","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2021.746430","article-title":"Development of the SciRAP approach for evaluating the reliability and relevance of in vitro toxicity data","volume":"3","author":"Roth","year":"2021","journal-title":"Front. Toxicol."},{"key":"10.1016\/j.bcp.2025.117575_b0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.106103","article-title":"Evaluating reliability and risk of bias of in vivo animal data for risk assessment of chemicals - Exploring the use of the SciRAP tool in a systematic review context","volume":"146","author":"Waspe","year":"2021","journal-title":"Environ. Int."},{"key":"10.1016\/j.bcp.2025.117575_b0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/rtph.1996.1076","article-title":"A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data","volume":"25","author":"Klimisch","year":"1997","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117575_b0500","unstructured":"J.E. McKenzie, S.E. Brennan, Chapter 12: Synthesizing and presenting findings using other methods [last updated October 2019]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024. Available from cochrane.org\/handbook."},{"key":"10.1016\/j.bcp.2025.117575_b0680","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, Oxman A, (editors). (2013) GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group. Available from guidelinedevelopment.org\/handbook."},{"key":"10.1016\/j.bcp.2025.117575_b0685","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2023.05.010","article-title":"(2023) the development methods of official GRADE articles and requirements for claiming the use of GRADE - a statement by the GRADE guidance group","volume":"159","author":"Sch\u00fcnemann","year":"2023","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.bcp.2025.117575_b0275","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jclinepi.2023.03.003","article-title":"GRADE guidance 36: updates to GRADE's approach to addressing inconsistency","volume":"158","author":"Guyatt","year":"2023","journal-title":"J. Clin. Epidemiol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117575_b0385","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.medj.2024.07.014","article-title":"Preclinical assessment for translation to humans: the PATH approach for assessing supporting evidence for early-phase trials and innovative care","volume":"5","author":"Kimmelman","year":"2024","journal-title":"Med."},{"key":"10.1016\/j.bcp.2025.117575_b0005","article-title":"Alteration effect of exendin-4 on oxidative stress and metabolic disorders induced by bisphenol a in adult male mice. Jentashapir","volume":"7","author":"Ahangarpour","year":"2016","journal-title":"J. Cell Mol. Biol."},{"key":"10.1016\/j.bcp.2025.117575_b0010","first-page":"321","article-title":"The effects of exendin-4 on glucose homeostasis, pancreatic and duodenal homebox 1, and glucose transporter 2 gene expression disturbance induced by bisphenol a in male mice. the effects of exendin-4 on pancreatic gene expression","volume":"27","author":"Ahangarpour","year":"2020","journal-title":"Roman. J. Diabetes Nutrit. Metabolic Dis."},{"key":"10.1016\/j.bcp.2025.117575_b0825","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ecoenv.2018.09.017","article-title":"Impairment of bisphenol F on the glucose metabolism of zebrafish larvae","volume":"165","author":"Zhao","year":"2018","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.bcp.2025.117575_b0280","doi-asserted-by":"crossref","first-page":"H1423","DOI":"10.1152\/ajpheart.00369.2015","article-title":"Insulin sensitizers prevent fine particulate matter-induced vascular insulin resistance and changes in endothelial progenitor cell homeostasis","volume":"310","author":"Haberzettl","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bcp.2025.117575_b0665","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/toxics6030055","article-title":"The NOAEL metformin dose is ineffective against metabolic disruption induced by chronic cadmium exposure in Wistar rats","volume":"6","author":"Sarmiento-Ortega","year":"2018","journal-title":"Toxics."},{"key":"10.1016\/j.bcp.2025.117575_b0750","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1038\/s41598-017-07544-7","article-title":"Involvement of insulin signaling disturbances in bisphenol A-induced Alzheimer's disease-like neurotoxicity","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117575_b0240","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/jcp.27318","article-title":"Taurine improves low-level inorganic arsenic-induced insulin resistance by activating PPAR\u03b3-mTORC2 signalling and inhibiting hepatic autophagy","volume":"234","author":"Gao","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2025.117575_b0660","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/toxsci\/kfab043","article-title":"Perfluorooctanesulfonic acid (PFOS) thwarts the beneficial effects of calorie restriction and metformin","volume":"182","author":"Salter","year":"2021","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bcp.2025.117575_b0380","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1007\/s00204-016-1889-2","article-title":"Polychlorinated biphenyls exposure-induced insulin resistance is mediated by lipid droplet enlargement through Fsp27","volume":"91","author":"Kim","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bcp.2025.117575_b0180","doi-asserted-by":"crossref","unstructured":"EFSA CEP Panel (EFSA Panel on Food Contact Materials, Enzymes and Processing Aids), Lambr\u00e9 C, Barat Baviera JM, Bolognesi C, Chesson A, Cocconcelli PS, Crebelli R, Gott DM, Grob K, Lampi E, Mengelers M, Mortensen A, Rivi\u00e8re G, Silano V (until 21 December 2020\u2020), Steffensen I-L, Tlustos C, Vernis L, Zorn H, Batke M, Bignami M, Corsini E, FitzGerald R, Gundert-Remy U, Halldorsson T, Hart A, Ntzani E, Scanziani E, Schroeder H, Ulbrich B, Waalkens-Berendsen D, Woelfle D, Al Harraq Z, Baert K, Carf\u00ec M, Castoldi AF, Croera C and Van Loveren H, 2023. Scientific Opinion on the re-evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs. EFSA Journal 21:6857. https:\/\/doi.org\/10.2903\/j.efsa.2023.6857.","DOI":"10.2903\/j.efsa.2023.6857"},{"key":"10.1016\/j.bcp.2025.117575_b0525","doi-asserted-by":"crossref","first-page":"12031","DOI":"10.1038\/s41598-020-68721-9","article-title":"Insulin signaling and glucose metabolism in different hepatoma cell lines deviate from hepatocyte physiology toward a convergent aberrant phenotype","volume":"10","author":"Molinaro","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117575_b0740","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1021\/es9038775","article-title":"Levels of polychlorinated biphenyls in human adipose tissue samples from southeast China","volume":"44","author":"Wang","year":"2010","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.bcp.2025.117575_b0730","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1289\/ehp.0901716","article-title":"Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol a","volume":"118","author":"Vandenberg","year":"2020","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bcp.2025.117575_b0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271668","article-title":"Interaction effect: are you doing the right thing?","volume":"17","author":"Garofalo","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117575_b0720","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4300\/JGME-D-12-00156.1","article-title":"Using effect size-or why the p value is not enough","volume":"4","author":"Sullivan","year":"2012","journal-title":"J. Grad. Med. Educ."},{"key":"10.1016\/j.bcp.2025.117575_b0560","article-title":"The therapeutic role of gastrodin in combating insulin resistance, inflammation, and oxidative stress induced by bisphenol-a","volume":"19","author":"Orji","year":"2024","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.bcp.2025.117575_b0700","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1152\/japplphysiol.00117.2008","article-title":"No effect of metformin on the innate airway hyperresponsiveness and increased responses to ozone observed in obese mice","volume":"105","author":"Shore","year":"2008","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bcp.2025.117575_b0565","doi-asserted-by":"crossref","first-page":"20102","DOI":"10.1038\/s41598-022-20655-0","article-title":"In vitro biochemical assessment of mixture effects of two endocrine disruptors on INS-1 cells","volume":"12","author":"Olaniyan","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117575_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.104904","article-title":"Identifying adipogenic chemicals: Disparate effects in 3T3-L1, OP9 and primary mesenchymal multipotent cell models","volume":"67","author":"Andrews","year":"2020","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bcp.2025.117575_b0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tox.2008.05.020","article-title":"Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats","volume":"250","author":"Boberg","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2025.117575_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2023.140852","article-title":"Environmental chemicals change extracellular lipidome of mature human white adipocytes","volume":"349","author":"Burkhardt","year":"2024","journal-title":"Chemosphere"},{"key":"10.1016\/j.bcp.2025.117575_b0115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1289\/ehp.1205701","article-title":"Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in mice","volume":"121","author":"Chamorro-Garc\u00eda","year":"2013","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bcp.2025.117575_b0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060030","article-title":"Evaluation of the INS-1 832\/13 cell line as a beta-cell based screening system to assess pollutant effects on beta-cell function","volume":"8","author":"Hectors","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117575_b0310","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/toxsci\/kfx166","article-title":"Exposure of pregnant mice to triclosan causes insulin resistance via thyroxine reduction","volume":"160","author":"Hua","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bcp.2025.117575_b0315","first-page":"419","article-title":"Presence of vasculature results in faster insulin response in adipocytes in vascularized adipose tissue model","volume":"36","author":"Huttala","year":"2019","journal-title":"ALTEX"},{"key":"10.1016\/j.bcp.2025.117575_b0545","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.3390\/molecules22112030","article-title":"The rosiglitazone-like effects of vitexilactone, a constituent from Vitex trifolia L. in 3T3-L1 preadipocytes","volume":"22","author":"Nishina","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2025.117575_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2022.107279","article-title":"Di-(2-ethylhexyl) phthalate substitutes accelerate human adipogenesis through PPAR\u03b3 activation and cause oxidative stress and impaired metabolic homeostasis in mature adipocytes","volume":"164","author":"Schaffert","year":"2022","journal-title":"Environ. Int."},{"key":"10.1016\/j.bcp.2025.117575_b0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.113608","article-title":"Luteolin protects against adipogenic and lipogenic potency induced by human relevant mixtures of persistent organic pollutants (POPs) in the 3T3-L1 model","volume":"173","author":"Xie","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bcp.2025.117575_b0805","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1743-7075-9-62","article-title":"Peroxisome proliferator-activated receptor gamma modulation and lipogenic response in adipocytes of small-for-gestational age offspring","volume":"9","author":"Yee","year":"2012","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.bcp.2025.117575_b0130","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jpain.2008.02.002","article-title":"Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats","volume":"9","author":"Churi","year":"2008","journal-title":"J. Pain"},{"key":"10.1016\/j.bcp.2025.117575_b0205","doi-asserted-by":"crossref","first-page":"19152","DOI":"10.1074\/jbc.M702724200","article-title":"The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis","volume":"282","author":"Feige","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117575_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115009","article-title":"Metabolomic-based assessment reveals dysregulation of lipid profiles in human liver cells exposed to environmental obesogens","volume":"398","author":"Franco","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117575_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2024.118847","article-title":"Metabolomics in human SGBS cells as new approach method for studying adipogenic effects: Analysis of the effects of DINCH and MINCH on central carbon metabolism","volume":"252","author":"Goerdeler","year":"2024","journal-title":"Environ. Res."},{"key":"10.1016\/j.bcp.2025.117575_b0340","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22368","article-title":"Metformin in contrast to berberine reversed arsenic-induced oxidative stress in mitochondria from rat pancreas probably via Sirt3-dependent pathway","volume":"33","author":"Javadipour","year":"2019","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bcp.2025.117575_b0360","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2337\/dc12-0388","article-title":"Systemic inflammation (C-reactive protein) in type 2 diabetic patients is associated with ambient air pollution in Pune City","volume":"36","author":"Khafaie","year":"2013","journal-title":"India. Diabetes Care."},{"key":"10.1016\/j.bcp.2025.117575_b0445","doi-asserted-by":"crossref","first-page":"76816","DOI":"10.1007\/s11356-022-21088-y","article-title":"Microarray analysis of mRNA expression profiles in liver of ob\/ob mice with real-time atmospheric PM2.5 exposure","volume":"29","author":"Lin","year":"2022","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.bcp.2025.117575_b0460","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1385\/ENDO:19:2:197","article-title":"Regulation of uncoupling protein-2 mRNA in L6 myotubules: I: Thiazolidinediones stimulate uncoupling protein-2 gene expression by a mechanism requiring ongoing protein synthesis and an active mitogen-activated protein kinase","volume":"19","author":"L\u00f3pez-Solache","year":"2002","journal-title":"Endocrine"},{"key":"10.1016\/j.bcp.2025.117575_b0505","article-title":"Long-term air pollution exposures on type 2 diabetes prevalence and medication use","volume":"7","author":"Meng","year":"2023","journal-title":"Hyg. Environ. Health Adv."},{"key":"10.1016\/j.bcp.2025.117575_b0515","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fphar.2017.00507","article-title":"Dibutyltin compounds effects on PPAR\u03b3\/RXR\u03b1 activity, adipogenesis, and inflammation in mammalian cells","volume":"8","author":"Milton","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117575_b0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077481","article-title":"Evaluation of a screening system for obesogenic compounds: screening of endocrine disrupting compounds and evaluation of the PPAR dependency of the effect","volume":"8","author":"Pereira-Fernandes","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117575_b0600","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jsbmb.2018.01.014","article-title":"Plasticizers used in food-contact materials affect adipogenesis in 3T3-L1 cells","volume":"178","author":"Pomatto","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bcp.2025.117575_b0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.110576","article-title":"Ivermectin decreases triglyceride accumulation by inhibiting adipogenesis of 3T3-L1 preadipocytes","volume":"131","author":"Qi","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bcp.2025.117575_b0625","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.toxlet.2018.10.025","article-title":"SirT3 regulates diabetogenic effects caused by arsenic: an implication for mitochondrial complex II modification","volume":"301","author":"Rezaei","year":"2019","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bcp.2025.117575_b0765","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/toxsci\/kfw100","article-title":"Generalized concentration addition modeling predicts mixture effects of environmental PPAR\u03b3 agonists","volume":"153","author":"Watt","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bcp.2025.117575_b0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2024.123761","article-title":"BDE-99 stimulates generation of aberrant brown\/beige adipocytes","volume":"347","author":"Wen","year":"2024","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.bcp.2025.117575_b0025","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.17582\/journal.pjz\/20220204050235","article-title":"Biochemical profiling of arsenic trioxide-induced impaired carbohydrate metabolism and its therapeutic intervention via modulation of metabolic pathways","volume":"54","author":"Akash","year":"2022","journal-title":"Pakistan J. Zool."},{"key":"10.1016\/j.bcp.2025.117575_b0335","doi-asserted-by":"crossref","DOI":"10.1093\/toxres\/tfaf071","article-title":"Protective effects of apricot kernel oil and metformin against BPA-induced ovarian toxicity in rat models of polycystic ovary syndrome: insights into PI3K\/AKT and mitochondrial apoptosis pathways","volume":"14","author":"Jiao","year":"2025","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.bcp.2025.117575_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2023.127299","article-title":"Metformin alleviates sodium arsenite-induced hepatotoxicity and glucose intolerance in mice by suppressing oxidative stress, inflammation, and apoptosis","volume":"80","author":"Molavinia","year":"2023","journal-title":"J. Trace Elem. Med Biol."},{"key":"10.1016\/j.bcp.2025.117575_b0760","first-page":"140","article-title":"Hypoglycemic and hypotriglyceridemic effects of tolbutamide in triphenyltin chloride-induced diabetic rabbits","volume":"44","author":"Watanabe","year":"2002","journal-title":"Vet. Hum. Toxicol."},{"key":"10.1016\/j.bcp.2025.117575_b0365","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41370-017-0001-1","article-title":"Particulate matter and markers of glycemic control and insulin resistance in type 2 diabetic patients: result from Wellcome Trust Genetic study","volume":"28","author":"Khafaie","year":"2018","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"10.1016\/j.bcp.2025.117575_b0815","doi-asserted-by":"crossref","first-page":"e1093","DOI":"10.1097\/MD.0000000000001093","article-title":"Air pollution and serum glucose levels: a population-based study","volume":"94","author":"Yitshak-Sade","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.bcp.2025.117575_b0630","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.envpol.2010.12.025","article-title":"Traffic exposure in a population with high prevalence type 2 diabetes\u2013do medications influence concentrations of C-reactive protein?","volume":"159","author":"Rioux","year":"2011","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.bcp.2025.117575_b0635","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.envpol.2015.03.012","article-title":"Medication type modifies inflammatory response to traffic exposure in a population with type 2 diabetes","volume":"202","author":"Rioux","year":"2015","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.bcp.2025.117575_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.162920","article-title":"Polychlorinated biphenyls, polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans, pesticides, and diabetes in the Anniston Community Health Survey follow-up (ACHS II): single exposure and mixture analysis approaches","volume":"877","author":"Pavuk","year":"2023","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.bcp.2025.117575_b0650","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/0960327107076886","article-title":"Exposure to persistent organochlorine pollutants and type 2 diabetes mellitus","volume":"26","author":"Rygnell-Hydbom","year":"2007","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.bcp.2025.117575_b0820","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.envpol.2018.01.046","article-title":"Associations of multiple plasma metals with incident type 2 diabetes in chinese adults: the Dongfeng-Tongji cohort","volume":"237","author":"Yuan","year":"2018","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.bcp.2025.117575_b0800","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0041-008X(77)90179-X","article-title":"The inhibitory effect of DDT on insulin secretion in mice","volume":"39","author":"Yau","year":"1977","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117575_b0135","article-title":"Metformin protects primary rat hepatocytes against oxidative stress-induced apoptosis","volume":"3","author":"Conde de la Rosa","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bcp.2025.117575_b0375","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1074\/jbc.M113.493650","article-title":"The role of prolyl hydroxylase domain protein (PHD) during rosiglitazone-induced adipocyte differentiation","volume":"289","author":"Kim","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117575_b0540","article-title":"In silico screening inhibitors histamine H2 chemical compounds in licorice plants (Glycyrrhiza glabra L.) using autodock vina. JFFI\/ Int","author":"Najib","year":"2019","journal-title":"J. Res Pharm. Sci."},{"key":"10.1016\/j.bcp.2025.117575_b0065","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13886","article-title":"A systematic review of evidence that environmental contaminant exposure impedes weight loss and glycemic control during calorie-restricted diets in humans","volume":"26","author":"Bennett","year":"2025","journal-title":"Obes. Rev."},{"key":"10.1016\/j.bcp.2025.117575_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116300","article-title":"A systematic review and meta-analysis of environmental contaminant exposure impacts on weight loss and glucose regulation during calorie-restricted diets in preclinical studies: Persistent organic pollutants may impede glycemic control","volume":"225","author":"Bennett","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117575_b0140","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/dom.13346","article-title":"Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017","volume":"20","author":"Curtis","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bcp.2025.117575_b0695","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010210","article-title":"Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study","volume":"6","author":"Sharma","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.bcp.2025.117575_b0300","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.70108","article-title":"Trends in pharmacological treatment of patients with new onset type 2 diabetes: usage patterns in an evolving guideline landscape","volume":"17","author":"Hou","year":"2025","journal-title":"J. Diabetes"},{"key":"10.1016\/j.bcp.2025.117575_b0345","doi-asserted-by":"crossref","first-page":"10856","DOI":"10.1038\/ncomms10856","article-title":"AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B","volume":"7","author":"Johanns","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117575_b0415","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jcb.23000","article-title":"Metformin sensitizes insulin signaling through AMPK-mediated pten down-regulation in preadipocyte 3T3-L1 cells","volume":"112","author":"Lee","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcp.2025.117575_b0465","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Madiraju","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117575_b0450","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jat.4383","article-title":"Perfluorooctane sulfonate promotes hepatic lipid accumulation and steatosis in high-fat diet mice through AMP-activated protein kinase\/acetyl-CoA carboxylase (AMPK\/ACC) pathway","volume":"43","author":"Ling","year":"2023","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.bcp.2025.117575_b0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.abb.2017.05.010","article-title":"The effects of troglitazone on AMPK in HepG2 cells","volume":"623\u2013624","author":"Allen","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2025.117575_b0215","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/10408444.2021.1888073","article-title":"Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?","volume":"51","author":"Fragki","year":"2021","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.bcp.2025.117575_b0550","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1289\/ehp.6316","article-title":"Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors","volume":"111","author":"Olsen","year":"2003","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bcp.2025.117575_b0775","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.envint.2017.06.007","article-title":"Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community","volume":"106","author":"Worley","year":"2017","journal-title":"Environ. Int."},{"key":"10.1016\/j.bcp.2025.117575_b0200","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.envpol.2018.12.095","article-title":"Levels, accumulation patterns and retrospective trends of perfluoroalkyl acids (PFAAs) in terrestrial ecosystems over the last three decades","volume":"246","author":"Falk","year":"2019","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.bcp.2025.117575_b0355","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s11356-009-0178-5","article-title":"Biomonitoring perfluorinated compounds in Catalonia, Spain: concentrations and trends in human liver and milk samples","volume":"17","author":"K\u00e4rrman","year":"2010","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.bcp.2025.117575_b0470","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/rcm.2661","article-title":"Determination of perfluorooctanoic acid and perfluorooctanesulfonate in human tissues by liquid chromatography\/single quadrupole mass spectrometry","volume":"20","author":"Maestri","year":"2006","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.bcp.2025.117575_b0555","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1021\/es020955c","article-title":"Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals","volume":"37","author":"Olsen","year":"2003","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.bcp.2025.117575_b0715","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.envint.2016.08.002","article-title":"Changes in serum levels of perfluoroalkyl substances during a 10-year follow-up period in a large population-based cohort","volume":"95","author":"Stubleski","year":"2016","journal-title":"Environ. Int."},{"key":"10.1016\/j.bcp.2025.117575_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijheh.2023.114119","article-title":"Harmonized human biomonitoring in European children, teenagers and adults: EU-wide exposure data of 11 chemical substance groups from the HBM4EU Aligned Studies (2014-2021)","volume":"249","author":"Govarts","year":"2023","journal-title":"Int. J. Hyg. Environ. Health"},{"key":"10.1016\/j.bcp.2025.117575_b0475","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/1091581811405544","article-title":"Effect of environmental contaminants on beta cell function","volume":"30","author":"Makaji","year":"2011","journal-title":"Int. J. Toxicol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117575_b0485","doi-asserted-by":"crossref","first-page":"E488","DOI":"10.1152\/ajpendo.00068.2023","article-title":"Endocrine disruptors in plastics alter \u03b2-cell physiology and increase the risk of diabetes mellitus","volume":"324","author":"Mart\u00ednez-Pinna","year":"2023","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2025.117575_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/endocr\/bqaa024","article-title":"Environmental obesogens and their impact on susceptibility to obesity: new mechanisms and chemicals","volume":"161","author":"Egusquiza","year":"2020","journal-title":"Endocrinol"},{"key":"10.1016\/j.bcp.2025.117575_b0430","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsbmb.2011.03.012","article-title":"The environmental obesogen tributyltin chloride acts via peroxisome proliferator activated receptor gamma to induce adipogenesis in murine 3T3-L1 preadipocytes","volume":"127","author":"Li","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bcp.2025.117575_b0435","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/cells11010086","article-title":"PPAR\u03b3 Regulates triclosan induced placental dysfunction","volume":"11","author":"Li","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.bcp.2025.117575_b0795","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/toxsci\/kfr140","article-title":"Organotins are potent activators of PPAR\u03b3 and adipocyte differentiation in bone marrow multipotent mesenchymal stromal cells","volume":"122","author":"Yanik","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bcp.2025.117575_b0370","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s00204-018-2268-y","article-title":"Tributyltin induces a transcriptional response without a brite adipocyte signature in adipocyte models","volume":"92","author":"Kim","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bcp.2025.117575_b0045","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005855","article-title":"Understanding contemporary use of thiazolidinediones","volume":"12","author":"Arnold","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.bcp.2025.117575_b0705","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/ijem.IJEM_646_18","article-title":"Drug prescription patterns and cost analysis of diabetes therapy in India: audit of an endocrine practice","volume":"23","author":"Singla","year":"2019","journal-title":"Indian J Endocrinol Metab."},{"key":"10.1016\/j.bcp.2025.117575_b0195","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4274\/jcrpe.2812","article-title":"Environmental contaminants and pancreatic Beta-cells","volume":"8","author":"Fabricio","year":"2016","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"10.1016\/j.bcp.2025.117575_b0420","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/db17-0188","article-title":"Low-dose persistent organic pollutants impair insulin secretory function of pancreatic \u03b2-Cells: human and in vitro evidence","volume":"66","author":"Lee","year":"2017","journal-title":"Diabetes"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T09:25:24Z","timestamp":1766395524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225008408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":165,"alternative-id":["S0006295225008408"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117575","relation":{},"ISSN":["0006-2952"],"issn-type":[{"type":"print","value":"0006-2952"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review and synthesis without meta-analysis (SWiM) reveals lack of clinical studies and weak preclinical evidence for interaction between glucose regulating drugs and environmental contaminant exposure","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117575"}}